跳至主要内容
临床试验/NCT01834118
NCT01834118已完成不适用

Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension

Cardiovascular Center Frankfurt1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Office Blood pressure measurement

研究概览

简要总结

The purpose of this study is to determine the effect of repeated renal denervation in non-responding patients with severe hypertension. Therefore ultrasound technique will be used.

详细描述

Renal Denervation is a CE-certified opportunity for treating patients with therapy-refractory hypertension. In some patients it doesn't show a significant lowering of the blood pressure, so a repeated renal denervation is an option.

In this study repeated renal denervation will be performed with the Recor Paradise Ultrasound Catheter.

For the study no specific procedures are required which would exceed the standard renal denervation procedure with the CE-certified Recor Paradise Ultrasound Catheter System.

There are no additional risks for the patient in consequence of participating in the study or the follow up procedures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Individual is ≥18 years old
  • •Individual received renal denervation ≥12 months prior to study participation to no therapeutical avail and is scheduled for reintervention.
  • •Systolic Office based blood pressure ≥140mmHg
  • •Individual receives 3 or more antihypertensive drugs including one diuretic
  • •Individual is willing to provide written informed consent to participate in this study

排除标准

  • •Individual has hypertension secondary to an identifiable and treatable cause
  • •Individual has any serious medical condition which in the opinion of the investigator may adversely affect the participation.
  • •Individual is pregnant, nursing or planning to be pregnant
  • •Renal artery abnormalities which may affect the procedure

结局指标

主要结局

Office Blood pressure measurement

时间窗: up to1 year

次要结局

未报告次要终点

研究者

发起方
Cardiovascular Center Frankfurt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Horst Sievert

M.D.

Cardiovascular Center Frankfurt

研究点 (1)

Loading locations...

相似试验